Successful treatment of behçet disease with pentoxifylline

Annals of Internal Medicine

Volumn 124, Issue 10, 1996, Pages 891-893

  Yasui, Kozo ^a   Ohta, Kouichi ^a   Kobayashi, Masakazu ^a   Aizawa, Toni ^a   Komiyama, Atsushi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; CYCLOSPORIN; HLA B ANTIGEN; PENTOXIFYLLINE; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; FEVER; FOLLICULITIS; HUMAN; HUMAN CELL; HYPOPYON; LEUKOCYTE MOTILITY; MALE; MEDICAL RECORD; MOUTH ULCER; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; UVEITIS; VISUAL DISORDER; DRUG EFFECT; IMMUNOLOGY; NEUTROPHIL;

ADOLESCENT; ADULT; BEHCET SYNDROME; CHEMOTAXIS, LEUKOCYTE; HUMANS; MALE; NEUTROPHILS; PENTOXIFYLLINE;

EID: 0029664831     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-10-199605150-00005     Document Type: Article

References (11)

1. Hill HR, Augustine NH, Newton JA. Shigeoka AO, Morris E, Sacchi F. Correction of a developmental defect in neutrophil activation and movement. Am J Pathol 1987,128 307-14.
2. Buescher ES, Mcllheran SM, Banks SM, Vadhan-Raj S. Alteration of the functional effects of granulocyte-macrophage colony-stimulating factor on polymorphonuclear leukocytes by membrane-fluidizing agents. Infect Immun 1990,58 3002-8.
3. Nelson RD, Quie PG, Simmons RL Chemotaxis under agarose a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975;115: 1650-6
4. Cohen HJ, Chovaniec ME. Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring super-oxide production and for the study of the activation of the generating system J Clin Invest 1978,61 1081-7.
5. Craddock PR, Hammerschmidt DE, Moldow CF, Yamada O, Jacob HS. Granulocyte aggregation as a manifestation of membrane interactions with complement, possible role in leukocyte margination, microvascular occlusion, and endothelial damage. Semin Hematol 1979;16 140-7
6. Yasui K, Komiyama A, Molski TF, Sha'afi RI. Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide possible mechanism of these actions Infect Immun. 1994;62:922-7
7. Matsumura N, Mizushima Y. Leucocyte movement and colchicine treatment in Behçet's disease [Letter] Lancet 1975:2:813
8. Kitagawa S, Takaku F. Effect of microtubule disrupting agents on superox ide production in human polymorphonuclear leukocytes. Biochim Biophys Acta 1982,719 589-98.
9. Aktulga E, Altac M, Muftuoglu A, Ozyazgan Y, Pazarli H, Tuzun Y, et al. A double blind study of colchicine in Behçet's disease. Haematologica. 1980;65 399-402
10. Yazici H, Barnes CG. Practical treatment recommendations for pharmacotherapy of Behçet's syndrome. Drugs. 1991,42 796-804.
11. Lingenfelser T, Duerk H, Stevens A, Grossmann T, Knorr M, Saal JG. Generalized myositis in Behçet disease treatment with cyclosporine. Ann Intern Med 1992,116 651-3